Genesis Global Group
Genesis Drug Discovery & Development
GD3

You will now be redirected to the GD3 website

Genesis Drug Discovery & Development is a proud member of Genesis Drug Discovery & Development (GD3), a fully integrated CRO providing services to support drug discovery programs of our clients from target discovery through IND filing and managing Phase I-III clinical trials.

Learn more about GD3
Search

Biochemistry & Bioanalytical

Cell-Based Assays

Empowering Drug Discovery with Precision Cell-Based Assays

Cell-based assays are the cornerstone of modern drug development, toxicology testing, and disease research. At GD3, our team of seasoned scientists is dedicated to crafting tailored cell-based assays that deliver actionable insights. Whether you're evaluating the efficacy of a promising drug candidate or unraveling the complexities of a disease, our precise assays provide the critical data you need.

  • Experience the GD3 difference:
    • Customized Solutions: We partner with you to design assays that perfectly align with your research goals.
    • Unparalleled Expertise: Our scientists bring years of experience and a deep understanding of cell biology to every project.
    • Reliable Results: Count on accurate, reproducible data to drive your research forward.
  • Types of cell-based assays:
    • ELISA
    • MSD
    • Fluorescent-based assays
    • Luminescence-based assays
    • Bioluminescent assays
    • Western blots
  • Applications:
    • Reporter bioassays (e.g. antibody dependent cell cytotoxicity, immune checkpoint)
    • Cell signaling (e.g. target engagement, kinase activity)
    • Cell health (e.g. apoptosis, cytotoxicity, proliferation, viability)
  • ADME Assays
    • Permeability assays
    • Metabolism assays
    • Drug-drug interaction assays (CYP450)
    • Toxicity pathway analysis
Figure 1. Assay parallelism: dilution of recombinant and endogenous PAX6 overlap indicating a lack of matrix effects in two cell lines. Symbols represent duplicates (±range, error bars are smaller than symbols).
Reference:
  • Phillip G. Zaworski, Rachel Schwartz, et al. Quantitation of Pax-6 protein in ocular impression cytology samples using an electrochemiluminescence immunoassay, Analytical Biochemistry, Volume 656, 2022, 114876, ISSN 0003-2697, https://doi.org/10.1016/j.ab.2022.114876.